Machine Learning Miscarriage Management Clinical Decision Support Tool Study
MLMM
MLMM
Sponsor study identifier
observational
1,000
1 country
1
Study Start
January 1, 2023
Actual (reported)Primary Completion
June 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Machine learning used to develop an algorithm to determine chance of success with expectant or medical management for an individual patient. Taking into account the following objective measures:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2023
Actual (reported)April 22, 2024
Actual (reported)April 25, 2024
Actual (reported)June 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Machine learning predictive model development for miscarriage management outcomes.
Machine learning predictive model development based on a retrospective audit of approximately 1000 cases of miscarriage.
Jan 2023- June 2024
Prospective audit to test and validate predictive model
July 2024-June 2025
Cohort that chose to pursue expectant management of miscarriage, final outcome success or failure by day 14 from management choice
Cohort that chose to pursue medical management of miscarriage, final outcome success or failure by day 14 from management choice
Expectant Management: Conservative management if miscarriage with follow-up booked in 2 weeks to determine whether complete miscarriage has occurred.
Medical Management: Misoprostol taken to manage first trimester miscarriage, with follow-up booked in 2 weeks to determine whether complete miscarriage has occurred.
Cases of missed miscarriage and incomplete miscarriage in the first trimester.
Imperial College Heatlhcare NHS Trust
London, W12 0HS, United Kingdom
First Submitted
April 22, 2024
First Posted
April 25, 2024
Study Start
January 1, 2023
Actual (reported)Primary Completion
June 1, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Misoprostol 400 µg Versus 200 µg for Cervical Ripening in 1st Trimester Miscarriage
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Study Completion
June 1, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 25, 2024
Record last verified: 2024-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: